In this article, we will explore ELF5 in depth, a topic that has generated a lot of interest and debate in recent times. ELF5 is a broad concept that covers different areas and aspects, from its impact on society to its implications in daily life. Throughout these pages, we will analyze ELF5 from various approaches, providing a complete and detailed vision of this topic that is so relevant today. Likewise, we will examine the historical evolution of ELF5, its possible future repercussions and the opinions of experts in the field. Regardless of your level of knowledge about ELF5, this article will provide you with valuable information and invite you to reflect on its importance and relevance in today's world.
E74-like factor 5 (ets domain transcription factor), is a gene found in both mice and humans.[5] In humans it is also called ESE2.
Function
The protein encoded by this gene is a member of an epithelium-specific subclass of the ETS transcription factor family. In addition to its role in regulating the later stages of terminal differentiation of keratinocytes, it appears to regulate a number of epithelium-specific genes found in tissues containing glandular epithelium such as salivary gland and prostate. It has very low affinity to DNA due to its negative regulatory domain at the amino terminus. Two alternatively spliced transcript variants encoding different isoforms have been described for this gene.[5]
Relevance to Disease
A role in breast or prostate cancer is known.[6] There are preliminary reports that the C allele genetic variant of rs61882275 near chromosome location 11.13 with variable incidence in human populations[7] is associated with severe COVID-19.[8] Further investigation by others suggested the association was caused by a tissue-specific effect on ELF5 expression in lung endothelium by this allele which results in a more than 4-fold higher risk of severe COVID-19 in those with SARS-CoV2 infection.[9]
^Kousathanas A, et al. (8 September 2021). "Whole genome sequencing identifies multiple loci for critical illness caused by COVID-19". medRxiv10.1101/2021.09.02.21262965.
^Pietzner M, et al. (19 January 2022). "ELF5 is a respiratory epithelial cell-specific risk gene for severe COVID-19". medRxiv10.1101/2022.01.17.22269283.
Further reading
Sharrocks AD, Brown AL, Ling Y, Yates PR (Dec 1997). "The ETS-domain transcription factor family". The International Journal of Biochemistry & Cell Biology. 29 (12): 1371–87. doi:10.1016/S1357-2725(97)00086-1. PMID9570133.
Lapinskas EJ, Palmer J, Ricardo S, Hertzog PJ, Hammacher A, Pritchard MA (Dec 2004). "A major site of expression of the ets transcription factor Elf5 is epithelia of exocrine glands". Histochemistry and Cell Biology. 122 (6): 521–6. doi:10.1007/s00418-004-0713-x. PMID15655699. S2CID28936823.
Tummala R, Sinha S (Mar 2006). "Differentiation-specific transcriptional regulation of the ESE-2 gene by a novel keratinocyte-restricted factor". Journal of Cellular Biochemistry. 97 (4): 766–81. doi:10.1002/jcb.20685. PMID16229011. S2CID46125527.